Liquid
Black Week
20% off everything with code BLACK
Click and the code is added to your cart.
Until Monday 30 Nov, 23:59 (Polish time).
Black Friday
20% off everything with code BLACK
Click and the code is added to your cart.
Until Monday 30 Nov, 23:59 (Polish time).
Last day
20% off everything with code BLACK
The code works until 23:59 today (Polish time).
Other categories
8 products
Black Week
Black Week deals before everyone else
Sign up for the newsletter and get access to the Black Week promotion before other customers.
By signing up you agree to receive the Pro-Body newsletter with news and promotions. You can unsubscribe at any time with one click in the e-mail. Privacy policy
SARMs in liquid form - research reagents
The compounds in this category reach the laboratory as a ready-made solution, usually 30 ml in volume. They are small molecules dissolved in a carrier, so, unlike lyophilised peptides, they do not need reconstituting first. The concentration in mg/ml is stated in the batch certificate of analysis and, in line with Research Use Only principles, describes the material, not a recommended amount.
The solutions cover SARMs (AR modulators) and compounds outside this class, with a different mechanism and a different WADA status. Both depend on the molecule, not on the form.
Characteristics of the form
The liquid form is a solution of a low-molecular-weight compound. The carrier may be propylene glycol or ethanol, and the label states which one.
SARMs in solution
The androgen receptor modulators in this form include LGD-4033 (Ligandrol), RAD-140 (Testolone) and Ostarine MK-2866. All of them act through the androgen receptor with tissue preference and appear on the WADA Prohibited List in section S1.2.
Non-SARM modulators in solution
Three compounds from outside the SARM class also come in solution. GW-501516 (Cardarine) is a PPARδ receptor agonist, SR-9009 (Stenabolic) a REV-ERB receptor agonist, and MK-677 (Ibutamoren) a growth hormone secretagogue. Each has a different mechanism and a different WADA code from the AR modulators.
Regulatory status
The SARMs (LGD-4033, RAD-140, Ostarine) appear on the WADA Prohibited List in section S1.2 (other anabolic agents). Cardarine (GW-501516), a PPARδ agonist, and SR-9009, a REV-ERB agonist, fall under section S4.4 (metabolic modulators), and MK-677, as a GH secretagogue, under section S2. Status is decided by the molecule, not by the solution form. Anyone registered in the ADAMS system must check the current list before any decision. None of the reagents is authorised as a medicine.
Applications in scientific research
Each compound in this form opens a different area of research. The researcher calculates working concentrations according to the protocol methodology, starting from the mg/ml value in the COA. The category gives no doses or cycles. The main research directions:
- Androgen receptor pharmacology: tissue profile and functional selectivity of SARMs in recombinant expression systems
- PPARδ signalling and lipid metabolism: PPARδ agonists (Cardarine) in models of fatty acid oxidation and aerobic capacity
- Circadian rhythm and metabolism: REV-ERB agonists (SR-9009), the so-called exercise mimetics, in animal models
- The GH/IGF-1 axis: ghrelin receptor secretagogues (MK-677) in growth hormone release models
- Batch identity and concentration: confirming structure by MS, HPLC purity and the declared concentration (mg/ml) in the COA
Scientific perspective
Data for these compounds come from cellular and animal models and, for some molecules, from early-phase studies. The strength and nature of the observed activity depend on the molecule and the model; the solution form describes only how the material is supplied. For GW-501516, preclinical data from animal models raise significant toxicological concerns, which underlines all the more strongly that the material is for research only.
Important distinction
A solution is a form, not a compound class. A shared form links neither mechanisms nor research directions. The identity of the material is decided by the structure and mass confirmed in the batch COA, not by the trade name. RUO principles rule out promises of physique effects.
Working with this form
- The solution is ready to use, without the reconstitution step typical of peptide lyophilisates
- The researcher reads the mg/ml concentration from the batch COA
- The solution is drawn with laboratory equipment (pipette, graduated syringe) in line with the protocol methodology
- Storage and protection from light and high temperature in line with the batch label
The same compounds in solid form are collected in the SARMs – capsules category. You will find the full list of AR modulators and related compounds in the parent SARMs category.
Frequently asked questions (FAQ)
Does the solution need reconstituting?
No. Unlike lyophilised peptides, the solution is ready to use and does not need dissolving. The researcher reads the mg/ml concentration from the COA for the batch in question.
Where can the reagent’s concentration in mg/ml be checked?
In the certificate of analysis (COA) for the batch in question. That value describes the material, not a recommended amount. The category gives no doses or cycles, because working concentrations are chosen by the researcher according to the methodology.
Are all the solutions in this category SARMs?
No. Alongside the AR modulators (LGD-4033, RAD-140, Ostarine), there are Cardarine GW-501516 and SR-9009 (metabolic modulators, WADA S4.4) and MK-677 (GH secretagogue, WADA S2). Only the form links them.
How can the identity of a compound in solution be confirmed?
The batch certificate of analysis (COA) confirms structure and mass by mass spectrometry and purity by HPLC. The trade name alone does not settle the molecule’s identity.